Juvenile Protective Factors and Their Effects on Aging (R03)
Funding Opportunity PAR-17-127 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite pilot/feasibility projects for: 1) descriptive studies to identify putative juvenile protective factors, 2) experimental studies to test hypotheses about their effects on aging and 3) translational studies to characterize potential beneficial and adverse effects of maintaining or modulating the level of juvenile protective factors in adult life. Juvenile protective factors (JPFs), intrinsic to an immature organism, help to maintain or enhance certain physiological functions across all or some stages of postna...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 18, 2017 Category: Research Source Type: funding
Juvenile Protective Factors and Their Effects on Aging (R01)
Funding Opportunity PAR-17-126 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite: 1) descriptive studies to identify putative juvenile protective factors, 2) experimental studies to test hypotheses about their effects on aging and 3) translational studies to characterize potential beneficial and adverse effects of maintaining or modulating the level of juvenile protective factors in adult life. Juvenile protective factors (JPFs), intrinsic to an immature organism, help to maintain or enhance certain physiological functions across all or some stages of postnatal development (i.e., segment ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 18, 2017 Category: Research Source Type: funding
Advanced Biomanufacturing of Therapeutic Cells (ABTC)
Preliminary Proposal Deadline Date: January 4, 2017 Preliminary Proposal Submission Deadline Program Guidelines: NSF 17-502In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, ...More at ...
Source: NSF Upcoming Due Dates - December 5, 2016 Category: Science Source Type: funding
Notice of Change in Application Due Date and Award Information for RFA-HL-15-030 "Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)"
Notice NOT-HL-16-464 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2016 Category: Research Source Type: funding
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)
Funding Opportunity ID: 287710 Opportunity Number: RFA-HL-17-018 Opportunity Title: Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.39593.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governm...
Source: Grants.gov - August 19, 2016 Category: Research Tags: Education Health Source Type: funding
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)
Funding Opportunity RFA-HL-17-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to participate as a Core Clinical Center/Consortia in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). This collaborative multi-center clinical program promotes the efficient comparison of novel treatment approaches and management strategies for potential benefit of children and adults undergoing hematopoietic stem cell transplantation (HCT), either alone or in combination with novel cell-based therapies. Collaboration among the Core Clinical Centers, the Data ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 19, 2016 Category: Research Source Type: funding
Biotechnology and Biochemical Engineering
Funding Opportunity ID: 287291 Opportunity Number: PD-16-1491 Opportunity Title: Biotechnology and Biochemical EngineeringOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 47.041Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: NSFAgency Name: National Science Fou...
Source: Grants.gov - August 11, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Biomedical Engineering (BME)
Funding Opportunity ID: 287249 Opportunity Number: PD-16-5345 Opportunity Title: Biomedical Engineering (BME)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 47.041Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: NSFAgency Name: National Science FoundationPosted...
Source: Grants.gov - August 10, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for the NIH-CASIS Coordinated Program in Tissue Chip Systems Translational Research in Space (UH2/UH3)
Opportunity ID: 287153 Opportunity Number: NOT-TR-16-018 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for the NIH-CASIS Coordinated Program in Tissue Chip Systems Translational Research in Space (UH2/UH3)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.350Eligible Applicants: State governmentsCounty governmentsCity or township governmentsIndependent school districtsPublic and State controlled institutions of higher educationNat...
Source: Grants.gov - August 8, 2016 Category: Research Tags: Health Source Type: funding
Request for Public Comment on the Proposed Changes to the NIH Guidelines for Human Stem Cell Research and the Proposed Scope of an NIH Steering Committees Consideration of Certain Human-Animal Chimera Research
Notice NOT-OD-16-128 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 4, 2016 Category: Research Source Type: funding
Biomedical Engineering (BME)
Funding Opportunity ID: 278085 Opportunity Number: PD-15-5345 Opportunity Title: Biomedical Engineering (BME)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 47.041Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: NSFAgency Name: National Science FoundationPosted...
Source: Grants.gov - August 2, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
Funding Opportunity PAR-16-322 from the NIH Guide for Grants and Contracts. This FOA encourages applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new techn...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 13, 2016 Category: Research Source Type: funding
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
Funding Opportunity Number: PAR-16-322 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.351Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS,...
Source: Grants.gov - June 13, 2016 Category: Research Tags: Health Source Type: funding
Notice of Correction of Application Open Date in PAR-16-094 "Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)"
Notice NOT-OD-16-075 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 3, 2016 Category: Research Source Type: funding
Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01)
Funding Opportunity Number: PAR-16-114 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCFDA Number: 93.865Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits havi...
Source: Grants.gov - February 25, 2016 Category: Research Tags: Health Income Security and Social Services Source Type: funding
